Home » Topics » Regulatory

Regulatory
RSS

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

CellPro seeks new indication for CEPRATE SC System

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.